SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc) ZPDH GY

Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

NAV USD (Official NAV)
$41,33
as of 08 Dec 2022
Base Fund Currency
USD
1 Day Nav Change
+$0,37 (+0,89%)
as of 08 Dec 2022
Assets Under Management
$496,02 M
as of 08 Dec 2022
TER
0,15%
image load fail
as of 30 Nov 2022

Fund Objective


The investment objective of the Fund is to track the performance of large sized U.S. health care companies in the S&P 500 Index.


Index Description


The Index measures the performance of U.S. equities that are classified as falling within the Health Care sector, as per the Global Industry Classification Standard (GICS). The GICS is a widely accepted industry analysis framework, jointly developed and maintained by MSCI and Standard & Poor's. Securities are weighted by market capitalisation.


Fund Information as of 10 Dec 2022

ISIN IE00BWBXM617
iNAV Ticker
INZPDHE
Inception Date 07 Jul 2015
Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Base Fund Currency USD
Income Treatment Accumulation
Settlement Cycle Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
Trading Cycle DD
TER 0,15%
Benchmark S&P Health Care Select Sector Daily Capped 25/20 Index
Minimum Investment 1 Share
Trading Currency EUR, GBP, MXN, USD
UCITS Compliant Yes
Domicile Ireland
Investment Manager State Street Global Advisors Europe Limited
Sub-Investment Manager(s)

State Street Global Advisors Trust Company

Fund Umbrella SSGA SPDR ETFs Europe II plc
Replication Method Replicated
Distribution Frequency -
PEA Eligible No
ISA Eligible Yes
SIPP Eligible Yes
UK Reporting Status Yes
Securities Lending No

Listing and Ticker Information as of 10 Dec 2022

Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
Deutsche Börse (Primary) EUR 08 Jul 2015 ZPDH BWD1N93 ZPDH GY ZPDH.DE
London Stock Exchange USD 09 Jul 2015 SXLV BWBXM61 SXLV LN SXLV.L
SIX Swiss Exchange USD 29 Oct 2015 SXLV BZ56MX4 SXLV SE SXLV.S
Borsa Italiana EUR 23 Feb 2016 SXLV BYVB5K4 SXLV IM SXLV.MI
Euronext Amsterdam EUR 31 Aug 2018 SXLV BDTYR79 SXLV NA SXLV.AS
Bolsa Mexicana de Valores MXN 15 Feb 2019 SXLVN BFYWDT6 SXLVN MM SXLVN.MX
London Stock Exchange GBP 04 Apr 2022 GXLV BNHSTT9 GXLV LN GXLV.L

INAV

Estimated NAV per Unit at 4PM, Hong Kong as of
Estimated NAV per Unit as of (Updated every 15 seconds)
As of (Updated every 15 seconds)
INAV TICKER CURRENCY INAV

The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.


Fund Characteristics as of 08 Dec 2022

Average Market Cap (M) $217 166,55 M
Number of Holdings 64
Average Price/Book 4,99
Price/Earnings Ratio FY1 17,25

Index Characteristics as of 08 Dec 2022

Index Dividend Yield
1,55%

Fund Market Price as of 08 Dec 2022

Bid Price €39,08
Offer Price €39,12
Closing Price €39,10
Bid/Offer Spread €0,04
Day High €39,24
Day Low €39,00
52 Week High €39,92
52 Week Low €32,36

Fund Net Asset Value as of 08 Dec 2022

NAV USD (Official NAV) $41,33
NAV EUR €39,20
NAV GBP £33,83
NAV MXN MXN $813,22
Assets Under Management $496,02 M
Shares in Issue 12 000 000

Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.


Fund Performance

  • Fund Inception Date: 07 Jul 2015
  • Index Inception Date: 27 Aug 2018

as of 30 Nov 2022

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year 10 Year Since Inception
07 Jul 2015
Fund Net 30 Nov 2022 4,77% 11,88% -0,39% 8,51% 46,32% 78,96% - 104,81%
Difference 30 Nov 2022 0,00% 0,00% 0,11% 0,11% 0,37% 0,84% - 1,57%
Fund Gross 30 Nov 2022 4,78% 11,92% -0,25% 8,67% 46,98% 80,30% - 107,10%
Difference 30 Nov 2022 0,01% 0,05% 0,25% 0,27% 1,03% 2,18% - 3,86%
Index
30 Nov 2022 4,77% 11,87% -0,49% 8,40% 45,95% 78,12% - 103,24%

as of 30 Nov 2022

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year 10 Year Since Inception
07 Jul 2015
Fund Net 30 Nov 2022 4,77% 11,88% -0,39% 8,51% 13,52% 12,35% - 10,17%
Difference 30 Nov 2022 0,00% 0,00% 0,11% 0,11% 0,10% 0,11% - 0,11%
Fund Gross 30 Nov 2022 4,78% 11,92% -0,25% 8,67% 13,69% 12,51% - 10,34%
Difference 30 Nov 2022 0,01% 0,05% 0,25% 0,27% 0,27% 0,27% - 0,28%
Index
30 Nov 2022 4,77% 11,87% -0,49% 8,40% 13,43% 12,24% - 10,06%

as of 30 Nov 2022

2022 (YTD) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Fund Net -0,39% 25,58% 12,96% 20,28% 6,01% 21,41% -3,08% -3,39% - - -
Difference 0,11% 0,04% 0,12% 0,10% 0,13% 0,10% 0,13% 0,10% - - -
Fund Gross -0,25% 25,77% 13,13% 20,46% 6,17% 21,59% -2,94% -3,32% - - -
Difference 0,25% 0,23% 0,29% 0,28% 0,29% 0,28% 0,28% 0,17% - - -
Index
-0,49% 25,54% 12,84% 20,18% 5,89% 21,31% -3,22% -3,49% - - -

Performance Gross and Net of All Fees.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.


Deviation & Tracking Error as of 30 Nov 2022

Standard Deviation 16,65%
Tracking Error 0,05%

This calculation is based on the past 3 years performance information.


Top Holdings

Fund Top Holdings as of 08 Dec 2022

Security Name Weight
UnitedHealth Group Incorporated 9,77%
Johnson & Johnson 8,96%
Eli Lilly and Company 5,64%
AbbVie Inc. 5,62%
Pfizer Inc. 5,42%
Merck & Co. Inc. 5,37%
Thermo Fisher Scientific Inc. 4,20%
Abbott Laboratories 3,53%
Danaher Corporation 3,38%
Bristol-Myers Squibb Company 3,28%
Download All Holdings: Download Daily Holdings

Industry Allocation

Fund Industry Allocation as of 08 Dec 2022

Sector Weight
Pharmaceuticals 30,53%
Health Care Providers & Services 23,52%
Health Care Equipment & Supplies 17,65%
Biotechnology 16,07%
Life Sciences Tools & Services 12,24%

Geographical Weights


Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

Capital Risk: Investing involves risk including the risk of loss of capital.

Past performance is not a guarantee of future results.

First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

Previous to 18 March 2019, this Fund's Benchmark was the S&P Health Care Select Sector Index.

It has come to our attention that the performance prior to February 2016 was quoted incorrectly for this Fund. For full details and corrected historical figures, please view the Notice of Performance Correction.

© 2022 Morningstar, Inc. All rights reserved. The information contained herein; (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. State Street does not review the Morningstar data.